Please assess the completion status of the following clinical trial:

Trial Title: Effect of Vitamin D After Application With Valchlor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be in general good health~* Fitzpatrick Skin Type I-VI~* Able to list all current medications and medical conditions~* Capable of giving informed consent~Exclusion Criteria:~* Women who are pregnant, nursing, or who may become pregnant in the next 3 months~* Participants taking illegal drugs~* Currently taking ketoconazole, colestipol, cholestyramine, phenobarbitol, phenytoin, or mineral oil~* Currently consuming 800IU or more of vitamin D a day~* Subjects whose BMI are \> 40

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1: 4 placebo - 0 Vitamin D with Valchlor (Type: PLACEBO_COMPARATOR): Participants will be given 4 placebo capsules and 0 cholecalciferol (Vitamin D) capsules after being treated with Valchlor.
- Group 2: 0 placebo - 4 Vitamin D with mechloroethamine (Type: EXPERIMENTAL): Participants will be given 0 placebo capsules and 4 cholecalciferol capsules to total 200,000 IU of cholecalciferol (Vitamin D) after being treated with Valchlor.

Based on this trial design, predict the completion outcome and termination type (if applicable).